National Disease Research Interchange
National Disease Research Interchange
NDRI's Service to Science Celebration: Honoring Distinguished Scientists, Vaccine Pioneers, and Organizations
Learn MoreNational Disease Research Interchange
National Institutes of Health funds Human Tissues and Organs for Research Resource Program
Learn moreNational Disease Research Interchange
Making strides to treat common and rare diseases with diverse programs & initiatives
National Disease Research Interchange
Supporting breakthrough scientific discoveries in Alzheimer’s Disease & AD Related Dementia (AD/ADRD)
Learn moreNational Disease Research Interchange
Giving patients and families an opportunity to leave a meaningful legacy
Consider donatingEvery year, NDRI distributes biospecimens to hundreds of investigators around the world who are working to advance many areas of science and healthcare. NDRI makes it easy for approved investigators to get much-needed biospecimens prepared, preserved and shipped precisely according the specific needs of the research protocol.
Request Process Request TissueResearchers continue to recognize NDRI as an invaluable partner as the need for human biomaterials grow. In response, NDRI has developed specialized programs to increase the supply of human tissues and organs for specific areas of research and has established a network of human tissue collection sites throughout the country to procure them.
Become a Partner See Our ProgramsThe Board of Directors of the National Disease Research Interchange (NDRI) is pleased to announce that Dr. Katalin Karikó and Dr. Drew Weissman, the scientists who led the research and technology development for the therapeutic use of mRNA – the foundation for the COVID vaccines developed by Pfizer/BioNTech and Moderna/NIH, will receive NDRI’s 2022 Empowering Research and Discovery Award. Click here to read more
-Philadelphia-based National Disease Research Interchange (NDRI) announces the election of Paul M. Lieberman, Ph.D., to its Board. Lieberman is the Hilary Koprowski, M.D., Endowed Professor, leader of the Gene Expression and Regulation Program, and director of the Center for Chemical Biology & Translational Medicine at The Wistar Institute, a biomedical research leader in cancer, immunology, infectious disease, and vaccine development. Elected on November 12 to a three-year term, Lieberman will bring his experience and insight to the nation’s leading source of human organs, cells and tissues for research.
Loading tweets...
NDRI is a Not-For-Profit (501c3) Corporation.
National Disease Research Interchange
Three Parkway
1601 Cherry Street, Suite 1700
Philadelphia, PA 19102
